Robert Young Kim - Chief Medical Officer at 4D Molecular Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
FDMT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Young Kim since 03 Feb 2025

Holdings reported by Robert Young Kim for 4D Molecular Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 92,300 06 Mar 2025 Direct Common Stock

Transactions reported by Robert Young Kim for 4D Molecular Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.